Altasciences wins the CRO Leadership 2024 award in the Capabilities category | Business

Altasciences wins the CRO Leadership 2024 award in the Capabilities category | Business
Altasciences wins the CRO Leadership 2024 award in the Capabilities category | Business

LAVAL, Quebec–(BUSINESS WIRE)–May 29, 2024–

Altasciences today announces that it has been recognized for its excellence in contract research with a CRO Leadership 2024 award in the Capabilities category. This distinction marks the ninth year that Altasciences, a fully integrated drug development solutions company, has been recognized as a top performer.

This press release contains multimedia elements. See the full press release here: https://www.businesswire.com/news/home/20240529176451/fr/

CRO Leadership Awards 2024: Capabilities (Graphic: Business Wire)

Clinical Leader and Life Science Leader partnered with ISR Reports to evaluate 42 CROs against more than 20 performance indicators in the annual survey CRO Quality Benchmarking of ISR. Respondents are qualified and only review companies they have worked with on an outsourced project in the last 18 months.

“For 12 years, Life Science Connect has worked alongside ISR Research to develop our annual CRO Leadership Awards. Receiving one of these awards is a testament to a company’s unwavering commitment to providing the highest level of service to the clinical research industry, and we congratulate the recipients for all their work,” says Dan Schell, Editor-in-Chief, Clinical Leader.

The Capabilities category assesses a CRO’s ability to provide a broad range of services, expertise, and resources across multiple therapeutic areas. Altasciences has transformed the traditional outsourcing paradigm by building a unique outsourcing solution with end-to-end services that securely simplifies and accelerates the early-stage drug development process for its clients.

“We are honored to be recognized as a leader in the CRO industry. Our mission has always been to provide the highest quality early-stage drug development solutions, with personalized services and a focus on efficiency. These awards recognize and validate the daily efforts of our employees to achieve our goal. I am extremely proud of our team,” says Chris Perkin, CEO, Altasciences.

With nine strategically placed research and manufacturing facilities across North America, Altasciences helps safely accelerate life-changing treatments for its customers, from lead candidate selection to demonstration of clinical feasibility.

About Altasciences

Altasciences is an integrated drug development solutions company providing pharmaceutical and biotechnology companies with a flexible and proven approach to preclinical and clinical pharmacology studies, including formulation, manufacturing and analytical services. For more than 25 years, Altasciences has partnered with sponsors to help them make informed, faster, more comprehensive decisions in early-stage drug development. Altasciences’ integrated, comprehensive solutions include preclinical safety testing, pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring and data management, all customizable based on specific sponsor requirements. Altasciences helps its sponsors bring better medicines faster to people who need them.

The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation must always be compared with the Source text, which will set a precedent.

View the Source version on businesswire.com:https://www.businesswire.com/news/home/20240529176451/en/

CONTACT: Julie-Ann Cabana

Altasciences

+1 514 601-9763

[email protected]

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH CONSULTING GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

Source: Altasciences

Copyright Business Wire 2024.

PUB: 05/29/2024 12:33 PM/DISC: 05/29/2024 12:33 PM

http://www.businesswire.com/news/home/20240529176451/en

-

-

NEXT at what time and on which channel to watch the fight?